Author

E. Akidil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

W. Hammerschmidt· 3 shared D. Pich· 2 shared A. Buschle· 1 shared A. Grundhoff· 1 shared A. Ruhle· 1 shared A. Sugimoto· 1 shared B. Mocanu· 1 shared J. Mautner· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

W. Hammerschmidt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and composition

Y.-F. A. Chen, B. Mocanu, E. Akidil, D. Pich, J. Mautner, W. Hammerschmidt

This study systematically analyzes EBV genes to identify those that improve virus production, composition, and uptake by human B cells.

bioRxiv · Apr 26, 2021 · PreprintMicrobiology

Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection

E. Akidil, M. Albanese, A. Buschle, A. Ruhle, O. T. Keppler, W. Hammerschmidt

bioRxiv · Oct 16, 2020Immunology

The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus

D. Pich, P. Mrozek-Gorska, M. Bouvet, A. Sugimoto, E. Akidil, A. Grundhoff, S. Hamperl, P. Ling, W. Hammerschmidt

This study identifies EBNA2 as essential for early EBV infection of naive B-cells, showing it drives activation, proliferation, and prevents cell death, while other latent genes have minimal or no effect during the pre-latent phase.

bioRxiv · Jun 11, 2019Microbiology